In addition, it addresses the FDA’s communications Together with the applicant, the retention of data that guidance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer possession of an SE report to a different applicant and Digital submission of the SE report